STS

HOUSTON — September 28, 2026 Moleculin Biotech, Inc. announced publication of a peer-reviewed pooled analysis of the cardiac safety...

SYDNEY, Australia – July 24, 2026 Immutep Limited has announced that an abstract from its investigator-initiated Phase II EFTISARC-NEO...